Navigation Links
Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
Date:7/21/2009

SOUTH SAN FRANCISCO, Calif., July 21 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product candidate. The Company worked collaboratively with the U.S. Food and Drug Administration (FDA) to design this study, which is required for new chemical entities.

This study evaluated the cardiac safety of picoplatin by determining its effect on the cardiac QT/QTc interval by using time-matched pharmacokinetics and electrocardiograms (ECGs). A total of 45 patients with advanced solid malignancies received 150 mg/m2 picoplatin. The trial was conducted at seven clinical sites in the United States. Results showed no clinical cardiac-related events. In addition, no evidence of a clinically relevant trend in any ECG parameter was demonstrated.

"With these new picoplatin safety data, we continue to make progress toward our goal of initiating the filing in 2009 of a New Drug Application for picoplatin as a second-line treatment for small cell lung cancer, with approval and commercialization targeted for 2010," said Robert De Jager, M.D., chief medical officer of Poniard. "More than 1,100 cancer patients have received picoplatin in clinical studies to date. Additional safety and anticipated efficacy data from our ongoing Phase 3 SPEAR study will provide a strong database to support the NDA filing."

The Company plans to present data from the Phase 1 cardiac safety trial at a medical conference later this year.

About Picoplatin

Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical dev
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Reportlinker.com announces that ... its catalogue: Portugal Pharmaceuticals and ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes 3 ... Faster-than-expected economic growth last quarter has led us ... upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... , July 28, 2014  UBM Medica US ... leading online community for medical imaging professionals, explored the ... value-based payment models . The shift from ... how the radiologist,s reimbursement is determined in the ... insight from leaders in the field, who recognized the ...
(Date:7/28/2014)... 2014  MedSpring Urgent Care, an Austin -based ... Lamar Blvd., Austin, TX 78704 on Saturday, ... the southeast corner of Barton Springs Rd. and S. ... 9 p.m. daily, including weekends and holidays. With existing ... Austin , Anderson Mill , Cedar Park ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Diagnostic Imaging Delves into Measuring the Radiologist's Value 2MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2
... May 17 Xenon Pharmaceuticals Inc. is pleased to announce ... Vice President, Research and Development. , ... "We are delighted to welcome Tarek to the Xenon team," ... world-class R&D executive whose experience in discovering products, a number of which ...
... TAI,AN, China , May ... CBPO ) ("China Biologic" or the "Company"), ... the People,s Republic of,China ("PRC"), operating through ... Ltd. ("Taibang") and Guiyang Dalin,Biologic Technologies Co., Ltd. ...
Cached Medicine Technology:Xenon Announces Appointment of EVP, Research & Development 2China Biologic Products Announces First Quarter 2010 Results 2China Biologic Products Announces First Quarter 2010 Results 3China Biologic Products Announces First Quarter 2010 Results 4China Biologic Products Announces First Quarter 2010 Results 5China Biologic Products Announces First Quarter 2010 Results 6China Biologic Products Announces First Quarter 2010 Results 7China Biologic Products Announces First Quarter 2010 Results 8China Biologic Products Announces First Quarter 2010 Results 9China Biologic Products Announces First Quarter 2010 Results 10China Biologic Products Announces First Quarter 2010 Results 11China Biologic Products Announces First Quarter 2010 Results 12China Biologic Products Announces First Quarter 2010 Results 13China Biologic Products Announces First Quarter 2010 Results 14China Biologic Products Announces First Quarter 2010 Results 15China Biologic Products Announces First Quarter 2010 Results 16China Biologic Products Announces First Quarter 2010 Results 17China Biologic Products Announces First Quarter 2010 Results 18
(Date:7/29/2014)... July 29, 2014 Tucson-based company ... employer’s benefits package, or health and wellness program, called ... while providing an effective way for employees to use ... of the program, employees specify the amount of each ... , An employer benefits from offering a 401(play)™ plan ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, ... new sleep experience. The top of each luxurious resort bed ... , These expertly crafted, 100% Egyptian cotton white duvets and ... yet upon closer look, words are woven in the linens ... breathe. , Intentional breathing and visualization are keys ...
(Date:7/29/2014)... 2014 In his latest blog post at ... CEO Per Wickstrom has listed 6 ways to light the ... creativity and avoid complacency, but for some it’s a losing ... progressive and powerful ways to help employees get to the ... as a whole.” , According to Per Wickstrom, 6 ways ...
(Date:7/29/2014)... Battle Creek, MI (PRWEB) July 29, 2014 ... treatment program that gets clients off to a great start ... believe in, was a proud sponsor of the National Cherry ... City, MI. , The concert, which was co-sponsored by Miller ... Collective Soul take to the Pepsi Bay Side Music Stage ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
Breaking Medicine News(10 mins):Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... Meeting of the American Political Science Association (APSA) will ... Metro Toronto Convention Centre, the InterContinental Toronto Centre, and ... time in its history that the meeting has been ... is the world,s largest gathering of political scientists; almost ...
... , ... its outreach to its current and future patients by its recent launch of accounts ... ... 2009 -- KoolDocs.com, the web,s leading resource for online medical consultations, diagnoses, prescriptions, and ...
... SCHAUMBURG, Ill., Aug. 27 Sagent Pharmaceuticals, Inc., ... has launched fluconazole injection in premix bags. IMS Health estimates ... Sagent will begin marketing and shipping fluconazole bags immediately. , ... again exemplified in our new fluconazole offering, the most recent ...
... , DES PLAINES, Ill. and NEW YORK, ... an agreement with Pfizer Inc to develop a molecular diagnostic test ... presence of gene rearrangements. Pfizer has developed a novel investigational ... many cancers. To be eligible to receive Pfizer,s oral therapy, ...
... , PRINCETON, N.J., Aug. 27 ... rare form of hemophilia are coming together at educational summits ... the Center for Biomedical Continuing Education (CBCE). For the fifth ... families with expert healthcare professionals and fellow patients to address ...
... , , , ... ) today announced that it has launched its newly updated online ... and motivated to live a healthier lifestyle. The free and open-to-everyone ... and other resources that allow people to share their experiences and ...
Cached Medicine News:Health News:105th APSA Meeting, world's largest for the study of politics, will be in Toronto Sept. 3-6 2Health News:KoolDocs.com Increases Online Presence through Social Networking Premium Online Medical Consultation Service Now on Facebook, Twitter, and LinkedIn 2Health News:Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready-to-Use IV Bags 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 3Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 4Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 2Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 3Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 4Health News:Weight Watchers(R) Launches New Community on WeightWatchers.com 2Health News:Weight Watchers(R) Launches New Community on WeightWatchers.com 3
Disposable Lacrimal Dilators...
Fine & Medium Tapers....
Skin Tone External Eyelid Weights...
Contour Design Eyelid Implants....
Medicine Products: